Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Matthew R. Box"'
Autor:
Jennifer E. Nelson, Graeme R. Robb, Martin R. Howard, Piotr Raubo, Paul D. Kemmitt, Kevin Blades, Junjie Shi, Tony Cheung, Qing Cao, Peter Barton, Andrew D. Ferguson, D. Bryan Prince, Shaun M. Fillery, Jun Hu, David J. Hargreaves, Roman D. Abrams, Nathan O. Fuller, Claudio Chuaqui, Eric Gangl, Matthew R. Box, Ning Gao, William McCoull, Kate Byth, Michael J. Waring, Jonathan Burgess, Xiahui Zhu, Matthew Grist, Erica Anderson, Nichole O'Connell, Philip B. Rawlins, Marta Wylot, David Whittaker, Rodrigo J. Carbajo, Erin Code
Publikováno v:
Journal of medicinal chemistry. 60(10)
Inhibition of the protein-protein interaction between B-cell lymphoma 6 (BCL6) and corepressors has been implicated as a therapeutic target in diffuse large B-cell lymphoma (DLBCL) cancers and profiling of potent and selective BCL6 inhibitors are cri
Autor:
Katrina S. Madden, Kevin Blades, Gillian M. Lamont, Matthew R. Box, Paul D. Kemmitt, William McCoull, Stephanie Dickinson, Jason D. Williams
Publikováno v:
The Journal of Organic Chemistry. 79:7682-7688
A new synthetic route to 3-(heteroaryl) tetrahydropyrazolo[3,4-c]pyridines has been developed that uses the Suzuki-Miyaura cross-coupling of a triflate 6 with (hetero)aryl boronic acids or esters. Using Pd(OAc)2 and XPhos or an XPhos precatalyst, a d
Publikováno v:
Synlett. 25:123-127
A range of useful disubstituted benzyl alcohol building blocks have been synthesised in multigram quantities in a lithium–bromide exchange to give aldehyde, carboxylic acid and pinacol boranes in high yields.
Autor:
Clare Lane, Nicola Colclough, Les A. Dakin, M. Raymond V. Finlay, Claudio Chuaqui, Mark J. Anderton, Christopher G. Chorley, Matthew Grist, Darren Cross, Richard A. Ward, Michael J. Waring, Teresa Klinowska, Jonathon P. Orme, Cath Eberlein, Judit E. Debreczeni, Scott W. Martin, Matthew R. Box, Peter D. Smith, Susan Ashton, Paul A. Bethel, Fengjiang Wang, Sam Butterworth, George B. Hill
Publikováno v:
Journal of Medicinal Chemistry. 56:7025-7048
A novel series of small-molecule inhibitors has been developed to target the double mutant form of the epidermal growth factor receptor (EGFR) tyrosine kinase, which is resistant to treatment with gefitinib and erlotinib. Our reported compounds also
Autor:
Pasi A. Jänne, Zhenfan Yang, Matthew R. Box, Dong Wan Kim, Matthew Grist, Mireille Cantarini, Angela Jordan, Peter Johnström, Peter Ballard, James Chih-Hsin Yang, Michael J. Hickey, Darren Cross, James W.T. Yates, Kenneth S. Thress, Jonas Malmquist, Kathryn Pickup, Katarina Varnäs
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 22(20)
Purpose: Approximately one-third of patients with non–small cell lung cancer (NSCLC) harboring tumors with EGFR-tyrosine kinase inhibitor (TKI)-sensitizing mutations (EGFRm) experience disease progression during treatment due to brain metastases. D
Autor:
Kevin Blades, Paul D. Kemmitt, William McCoull, Stephanie Dickinson, Jason D. Williams, Gillian M. Lamont, Matthew R. Box, Katrina S. Madden
Publikováno v:
ChemInform. 46
A new synthetic route to 3-(heteroaryl) tetrahydropyrazolo[3,4-c]pyridines has been developed that uses the Suzuki–Miyaura cross-coupling of a triflate 6 with (hetero)aryl boronic acids or esters. Using Pd(OAc)2 and XPhos or an XPhos precatalyst, a
Autor:
Peter Ballard, Michael James, Daniel S. James, Peter D. Smith, Simon J. Brown, M. Raymond V. Finlay, Michael J. Waring, Paula Perkins, Andrew D. Campbell, Heather L. McFarland, David Perkins, Gordon S. Currie, Gillian M. Lamont, Graham Richmond, Matthew R. Box, David Whittaker, Mark J. Anderton, Richard A. Ward, Teresa Klinowska, Scott G. Lamont, Nicola Colclough, Stuart L. Wells, Darren Cross, Gail L. Wrigley, George B. Hill, Nathaniel G. Martin, Paul D. Kemmitt, Susan Ashton, Lorraine A. Hassall, Paul A. Bethel, Robert Hugh Bradbury, Sam Butterworth, Christopher G. Chorley, Martine J. Mellor, Matthew Grist, Jonathon P. Orme
Publikováno v:
Journal of medicinal chemistry. 57(20)
Epidermal growth factor receptor (EGFR) inhibitors have been used clinically in the treatment of non-small-cell lung cancer (NSCLC) patients harboring sensitizing (or activating) mutations for a number of years. Despite encouraging clinical efficacy
Autor:
Julius Tibbelin, Jonathan D. Sellars, Michal Czyzewski, Patrick G. Steel, Tamaz Guliashvili, Lisa Johnstone, Henrik Ottosson, Matthew R. Box, Robert D. M. Davies, Justin Bower
Publikováno v:
ChemInform. 45
A derivative of (Ia) with a methyl-substituent at the terminal double bond yields no cycloadduct under the presented conditions.
Publikováno v:
ChemInform. 45
A range of useful disubstituted benzyl alcohol building blocks have been synthesised in multigram quantities in a lithium–bromide exchange to give aldehyde, carboxylic acid and pinacol boranes in high yields.
Autor:
Michal Czyzewski, Justin Bower, Patrick G. Steel, Robert D. M. Davies, Julius Tibbelin, Matthew R. Box, Lisa Johnstone, Henrik Ottosson, Tamaz Guliashvili, Jonathan D. Sellars
Publikováno v:
Chemical communications, 2014, Vol.50(22), pp.2919-2921 [Peer Reviewed Journal]
The synthesis of silaheterocycles through the first examples of an intramolecular silene Diels-Alder reaction is described.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac335446ed133d93321393c2ab0c897c
http://dro.dur.ac.uk/12062/
http://dro.dur.ac.uk/12062/